HRTX Heron Therapeutics, Inc. - Common Stock
$0,31
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 10, 2026
Zakres 52 tyg.
$0–$2
0% of range
Ocena Analityków
BUY
8 analysts
Cena Docelowa
$2
+553% upside
P/E (TTM)
-2.6
ROE
312.5%
Marża Zysku Netto
-13.0%
HRTX Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$0.31
Kapitalizacja Rynkowa
$58M
P/E (TTM)
-2.6
EPS (TTM)
$-0.12
Przychody (TTM)
$155M
Stopa dywidendy
—
ROE
312.5%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$0 – $2
HRTX Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$155M
2016-12-31
→
2025-12-31
EPS
$-0.12
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-28M
2016-12-31
→
2025-12-31
Marże
-13.0%
2023-12-31
→
2025-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
HRTX
Mediana porównawcza
P/E (TTM)
-2.6
—
P/S (TTM)
0.4
165.8
P/B
4.0
1.6
Price / FCF (Cena / FCF)
-2.1
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
HRTX
Mediana porównawcza
Gross Margin (Marża brutto)
73.3%
71.1%
Operating Margin (Marża Operacyjna)
-1.6%
—
Net Profit Margin (Marża Zysku Netto)
-13.0%
-2229.6%
ROA
-8.3%
-64.3%
ROE
312.5%
-102.1%
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
HRTX
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
2.5
4.8
Quick Ratio (Wskaźnik Szybkości)
1.2
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
HRTX
Mediana porównawcza
Revenue YoY (Przychody R/R)
7.4%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
12.9%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
11.8%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
HRTX
Mediana porównawcza
HRTX Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
8 analityków
- Mocne kupno 2 25,0%
- Kup 4 50,0%
- Trzymaj 2 25,0%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
1 analityków · 2026-08-13
Niski
$2.00
Wysoki
$2.00
Średni cel
$2.00
+553,2%
Średnia cel
$2.00
+553,2%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.01%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.03 | $0.01 | -0.04% |
| 31 marca 2026 | $-0.04 | $-0.02 | -0.02% |
| 31 grudnia 2025 | $-0.02 | $-0.02 | 0.00% |
| 30 września 2025 | $-0.04 | $-0.02 | -0.02% |
| 30 czerwca 2025 | $-0.02 | $-0.01 | -0.01% |
| 31 marca 2025 | $0.01 | $-0.01 | 0.02% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| HRTX | $245M | -10.8 | 7.4% | -13.0% | 312.5% | 73.3% |
| TENX | $114M | -9.1 | — | — | -52.5% | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
| MNOV | $64M | -5.5 | — | -2928.8% | -27.1% | — |
| BOLD | $27M | -0.5 | — | — | -46.7% | — |
| INMB | $41M | -0.8 | 257.1% | -91866.0% | -175.3% | — |
| EXOZ | $92M | -10.0 | — | — | -172.3% | — |
| INKT | — | -3.8 | 4.5% | -6931.8% | 63.4% | — |
| CLNN | $64M | — | -41.5% | -13086.5% | 200.2% | — |
| RNXT | — | -2.6 | 2511.6% | — | — | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $155M | $144M | $127M | $108M | $86M | $89M | $146M | $77M | $31M | $1M | |
| Cost of Revenue | $41M | $39M | $65M | $55M | $46M | $36M | $62M | $28M | $5M | $35.0K | |
| Gross Profit | $114M | $106M | $62M | $53M | · | · | · | · | · | · | |
| R&D Expense | $12M | $17M | $39M | $83M | $131M | $175M | $167M | $140M | $139M | $103M | |
| SG&A Expense | $55M | $53M | $66M | $62M | $40M | $42M | $38M | $29M | $26M | $21M | |
| Operating Expenses | $116M | $117M | $173M | $227M | $304M | $317M | $357M | $261M | $225M | $172M | |
| Operating Income | $-3M | $-12M | $-111M | $-175M | $-218M | $-228M | $-211M | $-184M | $-195M | $-171M | |
| Interest Expense | · | · | $4M | $2M | $2M | $2M | $1M | $3M | $4M | $3M | |
| Interest Income | $2M | $4M | $3M | $2M | $433.0K | $4M | $7M | $6M | $1M | $445.0K | |
| Other Non-op | $1M | $430.0K | $560.0K | $-7M | $-878.0K | $-847.0K | $158.0K | $2M | $-38.0K | $-9.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-20M | $-14M | $-111M | $-182M | $-221M | $-227M | $-205M | $-179M | $-197M | $-173M | |
| EPS (Basic) | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 | · | · | · | · | · | |
| EPS (Diluted) | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 | · | · | · | · | · | |
| Shares (Basic) | 166,707,000 | 152,449,000 | 138,135,000 | 108,876,000 | 98,471 | · | · | · | · | · | |
| Shares (Diluted) | 166,707,000 | 152,449,000 | 138,135,000 | 108,876,000 | 98,471 | · | · | · | · | · | |
| EBITDA | $-224.0K | $-9M | $-108M | $-172M | $-215M | $-225M | $-209M | $-182M | $-193M | $-171M |
Bilans 23
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $26M | $29M | $15M | $91M | $105M | $72M | $32M | $145M | $13M | |
| Short-term Investments | · | · | · | · | · | · | · | $301M | $28M | $38M | |
| Receivables | $90M | $79M | $60M | $52M | $35M | $42M | $40M | $65M | $42M | $2M | |
| Inventory | $93M | $53M | $42M | $55M | $48M | $42M | $25M | $39M | $10M | $5M | |
| Prepaid Expense | $9M | $18M | $6M | $14M | $13M | $22M | $23M | $11M | $4M | $4M | |
| Current Assets | $238M | $209M | $189M | $205M | $254M | $314M | $479M | $447M | $228M | $62M | |
| PP&E (Net) | $12M | $15M | $20M | $22M | $24M | $23M | $20M | $15M | $6M | $5M | |
| PP&E (Gross) | $25M | $33M | $37M | $36M | $37M | $34M | $28M | $23M | $14M | $12M | |
| Accum. Depreciation | $13M | $18M | $17M | $14M | $13M | $11M | $8M | $8M | $8M | $7M | |
| Other Non-current Assets | $5M | $6M | $8M | $16M | $18M | $346.0K | $346.0K | $254.0K | $263.0K | $263.0K | |
| Total Assets | $256M | $233M | $223M | $251M | $306M | $354M | $513M | $462M | $234M | $67M | |
| Accounts Payable | $9M | $12M | $3M | $3M | $4M | $525.0K | $3M | $17M | $19M | $7M | |
| Current Liabilities | $96M | $91M | $80M | $82M | $71M | $103M | $97M | $92M | $103M | $39M | |
| Capital Leases | $0 | · | $3M | $5M | $8M | $15M | $12M | · | · | · | |
| Other Non-current Liabilities | $5M | $615.0K | $241.0K | $241.0K | · | · | · | · | · | · | |
| Total Liabilities | $242M | $267M | $256M | $237M | $228M | $117M | $109M | $92M | $103M | $89M | |
| Common Stock | $2M | $2M | $2M | $1M | $1M | $913.0K | $903.0K | $782.0K | $646.0K | $394.0K | |
| Paid-in Capital | $1.95B | $1.88B | $1.87B | $1.81B | $1.69B | $1.63B | $1.57B | $1.33B | $914M | $564M | |
| Retained Earnings | $-1.94B | $-1.92B | $-1.91B | $-1.80B | $-1.61B | $-1.39B | $-1.17B | $-961M | $-783M | $-586M | |
| AOCI | $4.0K | $13.0K | $13.0K | $-19.0K | $-6.0K | $257.0K | $85.0K | $-87.0K | $-10.0K | $-17.0K | |
| Stockholders' Equity | $14M | $-34M | $-34M | $14M | $78M | $236M | $404M | $370M | $131M | $-21M | |
| Liabilities + Equity | $256M | $233M | $223M | $251M | $306M | $354M | $513M | $462M | $234M | $67M | |
| Shares Outstanding | 188,314,430 | 152,127,878 | 150,285,044 | 119,154,538 | 102,005,000 | 91,310,000 | 90,304,000 | 78,174,000 | 64,609,000 | 39,355 |
Przepływy pieniężne 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | |
| Stock-based Comp | $10M | $13M | $33M | $43M | $47M | $50M | $51M | $33M | $31M | $26M | |
| Restructuring | · | · | · | · | · | $6M | · | · | · | · | |
| Other Non-cash | $-20M | $-24M | $16M | $-11M | $-33M | $-11M | $27M | $-48M | $-5M | · | |
| Operating Cash Flow | $-28M | $-23M | $-59M | $-147M | $-203M | $-185M | $-125M | $-192M | $-170M | $-134M | |
| CapEx | $317.0K | $2M | $2M | $2M | $3M | $7M | $7M | $9M | $3M | $3M | |
| Investing Cash Flow | $16M | $19M | $18M | $-3M | $33M | $209M | $-22M | $-279M | $8M | $15M | |
| Net Debt Issued | · | · | · | · | · | · | · | $-25M | $-25M | · | |
| Stock Issued | $18M | · | $30M | $75M | · | · | $162M | $363M | $306M | · | |
| Net Stock Activity | $18M | · | $30M | $75M | · | · | $162M | · | · | · | |
| Financing Cash Flow | $14M | $940.0K | $54M | $75M | $156M | $9M | $186M | $358M | $294M | $57M | |
| Net Change in Cash | $3M | $-3M | $13M | $-75M | $-15M | $33M | $40M | $-113M | $131M | $-62M | |
| Free Cash Flow | $-28M | $-24M | $-60M | $-149M | $-206M | $-192M | $-132M | $-201M | $-173M | $-137M |
Rentowność 6
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.3% | 73.2% | 48.8% | · | · | · | · | · | · | · | |
| Operating Margin | -1.6% | -8.0% | -87.1% | -162.2% | -252.3% | -257.4% | -144.3% | -237.4% | -632.4% | -13363.2% | |
| Net Margin | -13.0% | -9.4% | -87.0% | -169.0% | -255.6% | -256.4% | -140.3% | -230.8% | -641.9% | -13537.4% | |
| EBITDA Margin | -0.14% | -6.3% | -84.8% | -159.5% | -248.8% | -254.2% | -142.9% | -235.5% | -627.4% | -13363.2% | |
| ROA | -8.3% | -6.0% | -46.7% | -65.4% | -67.0% | -52.5% | -42.0% | -51.3% | -130.9% | -168.7% | |
| ROE | 312.5% | 36.9% | 358.0% | -1010.6% | -224.7% | -88.5% | -59.4% | -46.0% | -359.4% | -357.5% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.3 | 2.4 | 2.5 | 3.6 | 3.1 | 5.0 | 4.9 | 2.2 | 1.6 | |
| Quick Ratio | 1.2 | 1.1 | 1.1 | 0.8 | 1.8 | 1.4 | 1.2 | 4.3 | 2.1 | 1.4 | |
| Interest Coverage | · | · | -28.6 | -70.6 | -90.4 | -120.0 | -143.1 | -68.8 | -49.4 | -64.2 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.5 | 0.4 | 0.3 | 0.2 | 0.3 | 0.2 | 0.2 | 0.0 | |
| Inventory Turnover | 0.6 | 0.8 | 1.3 | 1.1 | 1.0 | 1.1 | 1.9 | 1.1 | 0.6 | 0.0 | |
| Receivables Turnover | 1.8 | 2.1 | 2.3 | 2.5 | 2.2 | 2.2 | 2.8 | 1.5 | 1.4 | 1.3 |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.4% | 13.6% | 18.0% | 24.7% | -2.6% | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.9% | 18.7% | 12.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.8% | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $155M | $144M | $127M | $108M | $86M | $89M | $146M | $77M | $31M | $1M | |
| Net Income TTM | $-20M | $-14M | $-111M | $-182M | $-221M | $-227M | $-205M | $-179M | $-197M | $-173M | |
| Market Cap | $245M | $233M | $255M | $298M | $931M | $1.93B | $2.12B | $2.03B | $1M | $516M | |
| P/E | -10.8 | -17.0 | -2.1 | -1.5 | -4.1 | · | · | · | · | · | |
| P/S | 1.6 | 1.6 | 2.0 | 2.8 | 10.8 | 21.8 | 14.5 | 26.2 | 0.0 | 403.1 | |
| P/B | 17.1 | -6.9 | -7.5 | 21.9 | 12.0 | 8.2 | 5.3 | 5.5 | 0.0 | -24.3 | |
| P / Tangible Book | 17.1 | · | · | 21.9 | 12.0 | 8.2 | · | · | · | · | |
| P / Cash Flow | -8.9 | -10.3 | -4.3 | -2.0 | -4.6 | -10.5 | -17.0 | -10.6 | -0.0 | -3.8 | |
| P / FCF | -8.8 | -9.6 | -4.2 | -2.0 | -4.5 | -10.1 | -16.1 | -10.1 | -0.0 | -3.8 | |
| Earnings Yield | -9.2% | -5.9% | -47.1% | -66.8% | -24.5% | · | · | · | · | · |
Rachunek zysków i strat 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38M | $35M | $41M | $38M | $37M | $39M | $41M | $33M | $36M | $35M | $34M | $31M | $32M | $30M | $30M | $27M | |
| Cost of Revenue | $12M | $11M | $11M | $12M | $10M | $8M | $10M | $9M | $11M | $8M | $10M | $18M | $20M | $17M | $13M | $15M | |
| Gross Profit | $26M | $24M | $29M | $26M | $27M | $30M | $31M | $23M | $26M | $26M | $24M | $13M | $12M | $13M | $17M | $12M | |
| R&D Expense | $3M | $2M | $4M | $3M | $3M | $2M | $3M | $4M | $4M | $5M | $8M | $9M | $13M | $9M | $-14M | $26M | |
| SG&A Expense | $11M | $12M | $13M | $14M | $14M | $13M | $12M | $12M | $14M | $15M | $14M | $16M | $20M | $16M | $34M | $10M | |
| Operating Expenses | $28M | $29M | $29M | $30M | $29M | $27M | $26M | $28M | $32M | $31M | $35M | $38M | $54M | $46M | $10M | $54M | |
| Operating Income | $-2M | $-5M | $38.0K | $-4M | $-2M | $3M | $4M | $-4M | $-6M | $-5M | $-10M | $-25M | $-42M | $-33M | $-20M | $-42M | |
| Other Non-op | $-3M | $-3M | $5M | $-2M | $-744.0K | $-519.0K | $2M | $-390.0K | $-3M | $2M | $0 | $-79.0K | $344.0K | $295.0K | $1M | $-26.0K | |
| Net Income | $-5M | $-8M | $-3M | $-17M | $-2M | $3M | $4M | $-5M | $-9M | $-3M | $-11M | $-25M | $-42M | $-33M | $-20M | $-42M | |
| EPS (Basic) | $-0.03 | $-0.04 | $-0.02 | $-0.10 | $-0.02 | $0.02 | $0.02 | $-0.03 | $-0.06 | $-0.02 | $-0.01 | $-0.17 | $-0.35 | $-0.27 | $-0.11 | $-0.38 | |
| EPS (Diluted) | $-0.03 | $-0.04 | $-0.01 | $-0.10 | $-0.02 | $0.01 | $0.02 | $-0.03 | $-0.06 | $-0.02 | $-0.01 | $-0.17 | $-0.35 | $-0.27 | $-0.11 | $-0.38 | |
| Shares (Basic) | 190,335,000 | 189,646,000 | -311,151,000 | 170,348,000 | 154,020,000 | 153,490,000 | -303,885,000 | 152,830,000 | 152,305,000 | 151,199,000 | -245,820,000 | 144,990,000 | 119,719,000 | 119,246,000 | -207,387,000 | 111,735,000 | |
| Shares (Diluted) | 190,335,000 | 189,646,000 | -354,582,000 | 170,348,000 | 154,020,000 | 196,921,000 | -303,885,000 | 152,830,000 | 152,305,000 | 151,199,000 | -245,820,000 | 144,990,000 | 119,719,000 | 119,246,000 | -207,387,000 | 111,735,000 | |
| EBITDA | $-2M | $-4M | · | $-4M | $-2M | $4M | · | $-4M | $-6M | $-4M | · | $-25M | $-42M | $-32M | · | $-42M |
Bilans 22
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $26M | $29M | $43M | $17M | $19M | $26M | $26M | $18M | $20M | · | $35M | $13M | $27M | · | $50M | |
| Receivables | $90M | $84M | $90M | $81M | $80M | $79M | $79M | $67M | $74M | $65M | · | $64M | $77M | $51M | · | $42M | |
| Inventory | $91M | $93M | $93M | $70M | $73M | $57M | $53M | $46M | $43M | $42M | · | $42M | $45M | $52M | · | $52M | |
| Prepaid Expense | $7M | $8M | $9M | $23M | $17M | $26M | $18M | $11M | $7M | $7M | · | $11M | $11M | $15M | · | $8M | |
| Current Assets | $230M | $229M | $238M | $229M | $211M | $213M | $209M | $195M | $191M | $186M | · | $194M | $165M | $178M | · | $224M | |
| PP&E (Net) | $12M | $12M | $12M | $13M | $14M | $15M | $15M | $15M | $16M | $19M | · | $21M | $21M | $22M | · | $23M | |
| PP&E (Gross) | · | · | $25M | · | · | · | $33M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $13M | · | · | · | $18M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $7M | $7M | $8M | · | $8M | $9M | $14M | · | $17M | |
| Total Assets | $252M | $246M | $256M | $249M | $232M | $236M | $233M | $221M | $218M | $218M | · | $229M | $201M | $221M | · | $272M | |
| Accounts Payable | $12M | $9M | $9M | $12M | $12M | $12M | $12M | $10M | $10M | $837.0K | · | $2M | $2M | $4M | · | $7M | |
| Current Liabilities | $92M | $91M | $96M | $90M | $259M | $89M | $91M | $86M | $80M | $75M | · | $80M | $87M | $78M | · | $94M | |
| Capital Leases | $6M | · | · | · | · | · | · | $522.0K | $1M | $2M | · | $4M | $4M | $5M | · | $6M | |
| Other Non-current Liabilities | $5M | $5M | $5M | $5M | $747.0K | $682.0K | $615.0K | $241.0K | $241.0K | $241.0K | · | $241.0K | $241.0K | $241.0K | · | $241.0K | |
| Total Liabilities | $245M | $237M | $242M | $234M | $259M | $264M | $267M | $261M | $256M | $252M | · | $257M | $241M | $232M | · | $250M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $1M | $1M | $1M | · | $1M | |
| Paid-in Capital | $1.96B | $1.95B | $1.95B | $1.94B | $1.89B | $1.89B | $1.88B | $1.88B | $1.88B | $1.87B | · | $1.87B | $1.83B | $1.82B | · | $1.80B | |
| Retained Earnings | $-1.95B | $-1.95B | $-1.94B | $-1.94B | $-1.92B | $-1.92B | $-1.92B | $-1.92B | $-1.92B | $-1.91B | · | $-1.90B | $-1.87B | $-1.83B | · | $-1.78B | |
| AOCI | $-6.0K | $-6.0K | $4.0K | $0 | $-1.0K | $1.0K | $13.0K | $40.0K | $-8.0K | $-6.0K | · | $-1.0K | $-6.0K | $9.0K | · | $-57.0K | |
| Stockholders' Equity | $7M | $9M | $14M | $15M | $-27M | $-28M | $-34M | $-40M | $-38M | $-34M | $-34M | $-28M | $-39M | $-11M | $14M | $22M | |
| Liabilities + Equity | $252M | $246M | $256M | $249M | $232M | $236M | $233M | $221M | $218M | $218M | · | $229M | $201M | $221M | · | $272M | |
| Shares Outstanding | · | · | 188,314,430 | · | · | · | 152,127,878 | · | · | · | · | · | · | · | · | · |
Przepływy pieniężne 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $452.0K | $529.0K | $537.0K | $615.0K | $611.0K | $551.0K | $581.0K | $581.0K | $641.0K | $689.0K | $715.0K | $727.0K | $739.0K | $718.0K | $791.0K | $706.0K | |
| Stock-based Comp | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $5M | $3M | $4M | $7M | $14M | $8M | $11M | $11M | |
| Other Non-cash | · | $3M | · | · | · | $-15M | · | · | · | $-10M | · | · | · | $-797.0K | · | · | |
| Operating Cash Flow | $-2M | $-2M | $-9M | $1M | $-11M | $-9M | $-12M | $3M | $-5M | $-10M | $2M | $-9M | $-27M | $-25M | $-38M | $-37M | |
| CapEx | $138.0K | $391.0K | $0 | $0 | $208.0K | $109.0K | $638.0K | $431.0K | · | · | $250.0K | $793.0K | $278.0K | $224.0K | $414.0K | $45.0K | |
| Investing Cash Flow | $-3M | $-939.0K | $-5M | $12M | $7M | $2M | $11M | $4M | $2M | $1M | $-9M | $-23M | $13M | $37M | $2M | $-36M | |
| Stock Issued | · | · | $-2M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $82.0K | $-51.0K | $219.0K | $13M | $781.0K | $64.0K | $423.0K | $14.0K | $492.0K | $11.0K | $199.0K | $54M | $319.0K | $-208.0K | $439.0K | $75M | |
| Net Change in Cash | $-5M | $-3M | $-14M | $27M | $-3M | $-7M | $61.0K | $7M | $-2M | $-8M | $-6M | $21M | $-14M | $12M | $-35M | $2M | |
| Free Cash Flow | · | $-2M | · | · | · | $-9M | · | · | · | · | · | · | · | $-25M | · | · |
Rentowność 6
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.3% | 69.3% | · | 68.8% | 73.5% | 78.3% | · | 71.2% | 70.8% | 75.6% | · | 42.1% | · | · | · | · | |
| Operating Margin | -5.4% | -13.7% | · | -10.7% | -4.4% | 8.1% | · | -13.6% | -17.9% | -13.8% | · | -79.3% | -133.5% | -111.6% | · | -157.7% | |
| Net Margin | -14.6% | -23.4% | · | -45.8% | -6.4% | 6.8% | · | -14.8% | -25.6% | -9.1% | · | -79.6% | -132.4% | -110.7% | · | -157.8% | |
| EBITDA Margin | -5.4% | -12.2% | · | -10.7% | -4.4% | 9.5% | · | -13.6% | -17.9% | -11.8% | · | -79.3% | -133.5% | -109.2% | · | -157.7% | |
| ROA | -2.3% | -3.4% | · | -7.4% | -1.1% | 1.2% | · | -2.1% | -4.4% | -1.4% | · | -10.0% | -18.9% | -13.2% | · | -13.4% | |
| ROE | 53.9% | 84.0% | · | 139.3% | 7.3% | -8.5% | · | 14.3% | 23.9% | 14.0% | · | 937.3% | 137.8% | -523.1% | · | -59.3% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.5 | · | 2.6 | 0.8 | 2.4 | · | 2.3 | 2.4 | 2.5 | · | 2.4 | 1.9 | 2.3 | · | 2.4 | |
| Quick Ratio | 1.2 | 1.2 | · | 1.4 | 0.4 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | 1.0 | 1.0 | · | 1.0 |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.4 | 0.3 | · | 0.3 | |
| Receivables Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 0.6 | 0.5 | 0.6 | · | 0.6 |
Wycena (TTM) 4
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $148M | $149M | · | $147M | $145M | $142M | · | $135M | $134M | $127M | · | $119M | $116M | $107M | · | $101M | |
| Net Income TTM | $-33M | $-25M | · | $-22M | $-14M | $-15M | · | $-42M | $-79M | $-103M | · | $-142M | $-173M | $-195M | · | $-215M | |
| P/E | -2.3 | -5.3 | · | -9.0 | -20.7 | -22.0 | · | -7.1 | -5.8 | -3.4 | · | -0.9 | -0.7 | -0.8 | · | -2.0 | |
| Earnings Yield | -44.2% | -18.8% | · | -11.1% | -4.8% | -4.5% | · | -14.1% | -17.1% | -29.2% | · | -113.6% | -133.6% | -121.2% | · | -49.0% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $155M | $144M | $127M | $108M | $86M |
| Marża Brutto % | 73.3% | 73.2% | 48.8% | — | — |
| Marża Operacyjna % | -1.6% | -8.0% | -87.1% | -162.2% | -252.3% |
| Zysk netto | $-20M | $-14M | $-111M | $-182M | $-221M |
| Rozwodniony EPS | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 2.5 | 2.3 | 2.4 | 2.5 | 3.6 |
| Wskaźnik Szybkości | 1.2 | 1.1 | 1.1 | 0.8 | 1.8 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-28M | $-24M | $-60M | $-149M | $-206M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 184 emitenci · $51.8M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 25 (-7 vs poprzedni kw.) | 21 (-6 vs poprzedni kw.) | 50 (+3 vs poprzedni kw.) | 40 (-6 vs poprzedni kw.) | -15.3M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Rubric Capital Management LP | $12 823 986 | 30 046 828 | 24,76% | Akcje |
| Clearline Capital LP | $4 858 675 | 11 383 961 | 9,38% | Akcje |
| Velan Capital Investment Management LP | $3 735 904 | 8 753 290 | 7,21% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $3 323 230 | 7 782 741 | 6,42% | Akcje |
| Tejara Capital Ltd | $2 778 807 | 6 510 795 | 5,36% | Akcje |
| TANG CAPITAL MANAGEMENT LLC | $2 667 500 | 6 250 000 | 5,15% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $1 737 119 | 4 070 101 | 3,35% | Akcje |
| JW Asset Management, LLC | $1 600 958 | 3 751 073 | 3,09% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $1 543 336 | 3 614 773 | 2,98% | Akcje |
| VANGUARD GROUP INC | $1 500 729 | 1 154 407 | 2,90% | Akcje |
| Stonepine Capital Management, LLC | $1 500 000 | 1 000 000 | 2,90% | Opcja kupna |
| STATE STREET CORP | $1 377 948 | 3 228 557 | 2,66% | Akcje |
| Pale Fire Capital SE | $1 071 899 | 2 511 478 | 2,07% | Akcje |
| Caption Management, LLC | $896 280 | 2 100 000 | 1,73% | Opcja sprzedaży |
| Congress Park Capital LLC | $860 620 | 2 016 447 | 1,66% | Akcje |
| TWO SIGMA ADVISERS, LP | $675 442 | 519 571 | 1,30% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $674 878 | 1 580 510 | 1,30% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $643 145 | 1 506 900 | 1,24% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $582 906 | 1 365 119 | 1,13% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $547 071 | 1 281 796 | 1,06% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $519 613 | 1 217 463 | 1,00% | Akcje |
| Qube Research & Technologies Ltd | $435 802 | 1 021 092 | 0,84% | Akcje |
| Caption Management, LLC | $426 800 | 1 000 000 | 0,82% | Akcje |
| CM Management, LLC | $426 800 | 1 000 000 | 0,82% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $296 270 | 694 165 | 0,57% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $239 958 | 299 910 | 0,46% | Akcje |
| Stonepine Capital Management, LLC | $209 468 | 490 787 | 0,40% | Akcje |
| DIADEMA PARTNERS LP | $195 783 | 458 723 | 0,38% | Akcje |
| Xcelsior Advisor Partners LLC | $173 186 | 405 777 | 0,33% | Akcje |
| Apeiron RIA LLC | $158 163 | 370 579 | 0,31% | Akcje |
| Squarepoint Ops LLC | $137 078 | 321 177 | 0,26% | Akcje |
| Integrated Wealth Concepts LLC | $136 107 | 318 903 | 0,26% | Akcje |
| Glenmede Investment Management, LP | $132 710 | 105 326 | 0,26% | Akcje |
| Richmond Brothers, Inc. | $131 755 | 308 706 | 0,25% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $113 663 | 266 314 | 0,22% | Akcje |
| MARSHALL WACE, LLP | $105 194 | 244 638 | 0,20% | Akcje |
| NEXPOINT ASSET MANAGEMENT, L.P. | $99 359 | 232 800 | 0,19% | Akcje |
| FMR LLC | $96 800 | 226 803 | 0,19% | Akcje |
| Abel Hall, LLC | $90 987 | 213 185 | 0,18% | Akcje |
| CAROLINAS WEALTH CONSULTING LLC | $90 983 | 41 356 | 0,18% | Akcje |
| Horan Securities, Inc. | $86 091 | 41 590 | 0,17% | Akcje |
| RHUMBLINE ADVISERS | $83 482 | 195 537 | 0,16% | Akcje |
| Cutter & CO Brokerage, Inc. | $80 223 | 36 465 | 0,15% | Akcje |
| Quinn Opportunity Partners LLC | $74 837 | 175 344 | 0,14% | Akcje |
| GOLDMAN SACHS GROUP INC | $74 770 | 175 188 | 0,14% | Akcje |
| DLK Investment Management, LLC | $62 615 | 17 890 | 0,12% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $58 500 | 137 067 | 0,11% | Akcje |
| Bank of New York Mellon Corp | $54 073 | 126 693 | 0,10% | Akcje |
| D. E. Shaw & Co., Inc. | $51 402 | 120 435 | 0,10% | Akcje |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $51 341 | 120 293 | 0,10% | Akcje |
| Persistent Asset Partners Ltd | $49 974 | 117 090 | 0,10% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48 289 | 112 300 | 0,09% | Opcja kupna |
| BANK OF AMERICA CORP /DE/ | $46 165 | 108 369 | 0,09% | Akcje |
| Redwood Family Wealth LLC | $45 015 | 105 472 | 0,09% | Akcje |
| Biltmore Family Office, LLC | $42 680 | 100 000 | 0,08% | Akcje |
| DEUTSCHE BANK AG\ | $41 409 | 96 300 | 0,08% | Akcje |
| IEQ CAPITAL, LLC | $41 234 | 96 612 | 0,08% | Akcje |
| BARCLAYS PLC | $37 172 | 87 094 | 0,07% | Akcje |
| SEARLE & CO. | $36 812 | 86 250 | 0,07% | Akcje |
| Vanguard Global Advisers, LLC | $35 764 | 83 756 | 0,07% | Akcje |
| BlackRock, Inc. | $35 761 | 83 788 | 0,07% | Akcje |
| Russell Investments Group, Ltd. | $34 675 | 81 246 | 0,07% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $31 406 | 73 585 | 0,06% | Akcje |
| MERCER GLOBAL ADVISORS INC /ADV | $29 147 | 68 291 | 0,06% | Akcje |
| CITIGROUP INC | $28 050 | 65 721 | 0,05% | Akcje |
| Invesco Ltd. | $27 051 | 63 382 | 0,05% | Akcje |
| LPL Financial LLC | $26 083 | 61 112 | 0,05% | Akcje |
| COMMONWEALTH EQUITY SERVICES, LLC | $25 254 | 59 176 | 0,05% | Akcje |
| Anfield Capital Management, LLC | $24 003 | 30 000 | 0,05% | Akcje |
| Mariner, LLC | $23 896 | 55 972 | 0,05% | Akcje |
| NICOLET ADVISORY SERVICES, LLC | $23 840 | 16 000 | 0,05% | Akcje |
| Chicago Partners Investment Group LLC | $23 526 | 51 254 | 0,05% | Akcje |
| CWM, LLC | $23 115 | 28 890 | 0,04% | Akcje |
| Cerity Partners LLC | $22 473 | 52 654 | 0,04% | Akcje |
| CAPTRUST FINANCIAL ADVISORS | $22 000 | 51 547 | 0,04% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $20 003 | 46 868 | 0,04% | Akcje |
| R Squared Ltd | $19 935 | 46 708 | 0,04% | Akcje |
| Centiva Capital, LP | $19 422 | 45 507 | 0,04% | Akcje |
| Nuveen Asset Management, LLC | $19 408 | 12 685 | 0,04% | Akcje |
| INTECH INVESTMENT MANAGEMENT LLC | $17 990 | 42 150 | 0,03% | Akcje |
| HORAN Wealth, LLC | $17 751 | 41 590 | 0,03% | Akcje |
| Prospera Financial Services Inc | $17 308 | 40 565 | 0,03% | Akcje |
| Cornerstone Select Advisors, LLC | $17 057 | 39 964 | 0,03% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $16 647 | 38 987 | 0,03% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $16 369 | 38 352 | 0,03% | Akcje |
| GROUP ONE TRADING LLC | $16 196 | 37 947 | 0,03% | Akcje |
| Creative Planning | $15 306 | 35 862 | 0,03% | Akcje |
| Tower Research Capital LLC (TRC) | $15 180 | 35 567 | 0,03% | Akcje |
| HSBC HOLDINGS PLC | $14 464 | 33 381 | 0,03% | Akcje |
| DDFG, Inc | $14 043 | 32 903 | 0,03% | Akcje |
| Concurrent Investment Advisors, LLC | $13 625 | 31 923 | 0,03% | Akcje |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $13 425 | 32 397 | 0,03% | Akcje |
| CIBC WORLD MARKETS CORP | $13 215 | 10 165 | 0,03% | Akcje |
| Skopos Labs, Inc. | $12 744 | 15 927 | 0,02% | Akcje |
| CoreCap Advisors, LLC | $12 125 | 28 409 | 0,02% | Akcje |
| Vanguard Personalized Indexing Management, LLC | $11 641 | 27 276 | 0,02% | Akcje |
| DIVERSIFIED TRUST CO | $11 306 | 26 492 | 0,02% | Akcje |
| CITADEL ADVISORS LLC | $11 139 | 26 100 | 0,02% | Opcja kupna |
| Pallas Capital Advisors LLC | $10 968 | 25 699 | 0,02% | Akcje |
| JANE STREET GROUP, LLC | $10 957 | 25 672 | 0,02% | Akcje |
Insiderzy spółki 39 insiderów · 21 dyrektorzy generalni · 21 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Craig A Collard | Chief Executive Officer | 31 lipca 2026 M | 856 492 | 0 | 0 | $0 |
| Barry D Quart | Chief Executive Officer | 18 stycznia 2023 A | 177 989 | 0 | 0 | $0 |
| Ronald J Prentki | President & CEO | 17 lutego 2010 A | 40 539 | 0 | 0 | $0 |
| Michael Oconnell | Chief Executive Officer | 10 stycznia 2006 A | 132 200 | 0 | 0 | $0 |
| Ira Duarte | EVP, Chief Financial Officer | 31 lipca 2026 M | 281 899 | 0 | 0 | $0 |
| Robert Hoffman | CFO & SVP, Finance | 19 grudnia 2019 A | 1 280 | 0 | 0 | $0 |
| Brian G. Drazba | VP, Finance & CFO | 31 października 2016 J | 3 798 | 0 | 0 | $0 |
| John Whelan | CFO | 18 lipca 2013 M | 254 088 | 0 | 0 | $0 |
| Stephen Whiteford | V.P., Finance & CFO | 15 grudnia 2006 A | 15 000 | 0 | 0 | $0 |
| John Poyhonen | President & CCO | 13 kwietnia 2023 M | 46 648 | 0 | 0 | $0 |
| Robert Rosen | President | 15 grudnia 2018 A | 2 640 | 0 | 0 | $0 |
| David Leslie Szekeres | EVP, Chief Operating Officer | 13 lipca 2023 M | 33 754 | 0 | 0 | $0 |
| Michael A Adam | Chief Operating Officer | 8 lutego 2013 A | — | 0 | 0 | $0 |
| William P Forbes | EVP, Chief Development Officer | 31 lipca 2026 M | 241 173 | 0 | 0 | $0 |
| Lisa Peraza | VP, Chief Accounting Officer | 19 stycznia 2024 A | 55 907 | 0 | 0 | $0 |
| Kimberly Manhard | EVP, Drug Development | 13 kwietnia 2023 M | 28 330 | 0 | 0 | $0 |
| Marshall Paul | SVP, Technical Operations | 21 marca 2016 M | 2 200 | 0 | 0 | $0 |
| Neil James Clendeninn | SVP & Chief Medical Officer | 12 października 2015 A | — | 0 | 0 | $0 |
| Mark S. Gelder MD | SVP & Chief Medical Officer | 12 grudnia 2014 A | — | 0 | 0 | $0 |
| John Barr | Vice President of R&D | 8 lipca 2011 A | 51 772 | 0 | 0 | $0 |
| Anastassios D. Retzios | VP of Clinical Development | 15 stycznia 2008 A | — | 0 | 0 | $0 |
| Thomas Cusack | Dyrektor | 30 stycznia 2026 A | 53 960 | 0 | 0 | $0 |
| Morgan Adam | Dyrektor | 30 stycznia 2026 A | 123 737 | 0 | 0 | $0 |
| Sharmila Dissanaike | Dyrektor | 30 stycznia 2026 A | 53 960 | 0 | 0 | $0 |
| Michael Kaseta | Dyrektor | 30 stycznia 2026 A | 53 960 | 0 | 0 | $0 |
| Waage Christian | Dyrektor | 30 stycznia 2026 A | 53 960 | 0 | 0 | $0 |
| Craig A Johnson | Dyrektor | 30 stycznia 2026 A | 53 960 | 0 | 0 | $0 |
| Susan Rodriguez | Dyrektor | 31 stycznia 2025 A | 87 180 | 0 | 0 | $0 |
| Stephen Davis | Dyrektor | 16 grudnia 2022 A | 52 032 | 0 | 0 | $0 |
| KEVIN TANG | Dyrektor | 19 grudnia 2019 A | 5 799 810 | 0 | 0 | $0 |
| Greg Turnbull | Dyrektor | 29 maja 2012 A | 245 092 | 0 | 0 | $0 |
| Paul Goddard | Dyrektor | 29 maja 2012 A | 214 683 | 0 | 0 | $0 |
| Toby Rosenblatt | Dyrektor | 20 maja 2010 A | 210 234 | 0 | 0 | $0 |
| Robert L Zerbe MD | Dyrektor | 20 maja 2010 A | 202 072 | 0 | 0 | $0 |
| Peter Riepenhausen | Dyrektor | 28 maja 2008 A | 9 000 | 0 | 0 | $0 |
| Arthur T Taylor | Dyrektor | 28 maja 2008 A | 12 000 | 0 | 0 | $0 |
| Dennis L Winger | Dyrektor | 11 sierpnia 2006 A | 69 544 | 0 | 0 | $0 |
| Stephen A Drury | Dyrektor | 11 sierpnia 2006 J | 83 283 | 0 | 0 | $0 |
| Mark Earl Hensley | — | 6 sierpnia 2026 M | 170 901 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 3 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Rubric Capital Management LP, David Rosen ×6 zgłoszenia | 17 października 2025 | 15,90% | Aneks | — | SEC |
| Tang Capital Partners, LP, Tang Capital Management, LLC, Kevin Tang ×20 zgłoszenia | 7 stycznia 2020 | — | Pierwotne zgłoszenie | — | SEC |
| Felix J. Baker, Julian C. Baker ×3 zgłoszenia | 7 lipca 2011 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 22 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,28% | 128 515 SH | 8 sierpnia 2026 | Dziennie |
| IWC · iShares Trust | 0,02% | 537 335 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 67 617 NS | 30 kwietnia 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 1 328 289 SH | 8 sierpnia 2026 | Dziennie |
| ITWO · ProShares Trust | 0,00% | 7 231 NS | 31 maja 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 198 683 SH | 8 sierpnia 2026 | Dziennie |
| SCHA · SCHWAB STRATEGIC TRUST | 0,00% | 869 904 NS | 31 maja 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 3 609 893 SH | 8 sierpnia 2026 | Dziennie |
| UWM · ProShares Trust | 0,00% | 5 655 NS | 31 maja 2026 | N-PORT |
| IWN · iShares Trust | 0,00% | 505 371 SH | 8 sierpnia 2026 | Dziennie |
| URTY · ProShares Trust | 0,00% | 5 714 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 144 NS | 31 maja 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 4 190 NS | 31 maja 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 83 361 NS | 31 maja 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 28 626 SH | 8 sierpnia 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 2 063 361 SH | 8 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 5 474 947 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 925 988 SH | 8 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 13 208 SH | 8 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 156 616 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 12 513 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,00% | 472 185 SH | 8 sierpnia 2026 | Dziennie |